Summary of ZALICUS INC. - Yahoo! Finance

Quotes & Info

Enter Symbol(s):
e.g. YHOO, ^DJI

Symbol Lookup | Financial Search

ZLCS > SEC Filings for ZLCS > Form 8-K on 4-Sep-2012

All Recent SEC Filings

Show all filings for ZALICUS INC. | Request a Trial to NEW EDGAR Online Pro

Form 8-K for ZALICUS INC.

4-Sep-2012

Other Events, Financial Statements and Exhibits

Item 8.01. Other Events.

On September 4, 2012, Zalicus Inc. ("Zalicus") issued a press release announcing the initiation of the first of two Phase 2a clinical trials with its product candidate Z160, an N-type calcium channel blocker for the treatment of chronic pain. The full text of Zalicus's press release regarding the announcement is filed as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits

Exhibit No. Description
99.1 Press release of Zalicus Inc. dated September 4, 2012.

Add ZLCS to Portfolio

Set Alert

Email to a Friend

Get SEC Filings for Another Symbol: Symbol Lookup

Quotes & Info for ZLCS - All Recent SEC Filings

Sign Up for a Free Trial to the NEW EDGAR Online Pro
Detailed SEC, Financial, Ownership and Offering Data on over 12,000 U.S. Public Companies.
Actionable and easy-to-use with searching, alerting, downloading and more.
Request a Trial Sign Up Now

Copyright © 2013 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.